Objectives: To investigate the role of a putative small multidrug resistance transporter, annotated in Enterococcus faecalis V583 genome as EFA0010 (we will refer to this gene as qacZ), in decreased susceptibility to biocides.
Introduction
In the past few decades, the use of biocides as antiseptics, disinfectants and preservatives has been growing, not only in the hospital environment, but also in the food industry and more recently in our homes. This practice has been suggested to contribute to selection of antibiotic-resistant bacteria, and may lead to a decrease in the number of solutions to control bacterial load in hospital settings, in the food industry and even at home. 1 Thus, the need to understand the mechanisms responsible for biocide tolerance in bacteria causing severe infections is obvious and urgent. Enterococci are Gram-positive commensal bacteria that inhabit the gastrointestinal tract of humans and animals. Their robust nature allows them to disseminate in a variety of other habitats, namely fermented foods, water, soil and plants. Members of this genus have intrinsic and acquired resistance to several antibiotics and thus became the second most frequently reported cause of surgical wound and nosocomial urinary tract infections and the third most frequently reported cause of bacteraemia. 2 However, and despite their relevance as nosocomial multiresistant pathogens, there are no tolerance mechanisms to biocides described so far for the genus Enterococcus. Among Staphylococcus isolates qac genes, encoding small multidrug resistance (SMR) transporters, mediate resistance to quaternary ammonium compounds (QACs). 3 reading frame, EFA0010, annotated as a putative SMR transporter. In this work we provide evidence that supports this activity of EFA0010 and we will thus refer to it as the qacZ gene.
Materials and methods

MIC determination
MICs, determined according to the CLSI (formerly the NCCLS), 5 of benzalkonium chloride, a QAC, chlorhexidine, a biguanidine, and ethidium bromide, a dye, were compared for two strains: V583ErmS [a derivative of E. faecalis V583, susceptible to erythromycin due to deletion of the erm(B) gene (EFA0007), kindly supplied by Axel Hartke, from Caen, France]; and EF-SAVE1 (a derivative of V583ErmS carrying the high-copy-number plasmid pSAVE1, constructed in the present study).
Construction of the EF-SAVE1 strain
For pSAVE1 construction, the qacZ gene was amplified from V583 using qac-EF (GAATCGGATCCATCACTTAATAAAGGAGC) and qac-ER (GAATCCTGCA-GATACACTAAACAAAGTGGGC) primers. qac-EF has a restriction site for BamHI and qac-ER has a restriction site for PstI, both underlined. The PCR product (480 bp) contained both the coding sequence and the ribosome binding site of qacZ, but excluded the promoter regions. The amplicon and the pORI23 plasmid 6 were digested and ligated to construct pSAVE1. The ligation mixture was introduced into electrocompetent Escherichia coli DH5a cells. Transformants were selected on LuriaBertani agar containing 500 mg/L erythromycin, and the presence of qacZ under pORI23 promoter regulation was confirmed by sequencing. The EF-SAVE1 strain was constructed by introducing pSAVE1 into electrocompetent V583ErmS cells and transformants were selected on brain heart infusion (BHI) agar containing 500 mg/L erythromycin.
RT-PCR
RT-PCR was performed in order to confirm whether a higher copy number of EFA0010 in V583ErmS led to higher expression of this gene and consequently a higher MIC of benzalkonium chloride. Total RNA was isolated from V583ErmS, EF-SAVE1 and EF-SAVE2 (V583ErmS containing pORI23 without the amplicon) by means of the RNeasy Mini Kit (Qiagen). RNA was reverse transcribed using a Transcriptor High Fidelity cDNA Synthesis Kit (Roche). RT-PCR was performed using qac-IF and qac-IR primers.
Ethidium bromide efflux assay
Ethidium bromide efflux assays were performed in accordance with Jonas et al. 7 Briefly, overnight cultures of V583ErmS and EF-SAVE1 were washed with 20 mM HEPES buffer and resuspended in the same buffer. After that, cells were loaded with ethidium bromide (2.5 mM) by shaking at 378C and adding carbonyl cyanide 3-chloro-phenylhydrazone (CCCP) at 40 mM. Cells were incubated for 1 h and after that they were Figure 1 . Alignment of QacZ with homologous proteins in the database (BLASTP, NCBI), with identities .60%. QacZ has Glu-13 (E), which is conserved throughout the SMR family and is absolutely required for drug efflux activity. Putative transmembrane helix sequences of QacZ, a hydrophobic protein (SOUSI 1.1.), are represented by horizontal lines above the aligned sequences. Conserved amino acid residues are indicated by bold letters. NP_816940 is QacZ from E. faecalis V583, O87868 is QacH from Staphylococcus saprophyticus, NP_647561 is an ethidium bromide resistance determinant from Staphylococcus epidermidis, Q55339 is QacC from Staphylococcus sp. ST827, AAB47993 is an SMR efflux pump from S. aureus, N_783299 is a QAC resistance protein from S. aureus and O87866 is QacG from Staphylococcus sp. ST94.
washed with HEPES buffer containing ethidium bromide (2.5 mM). Cells were stored in ice until efflux was initiated by addition of BHI. Efflux was measured using a Cary Eclipse Fluorescence Spectrofluorimeter Varian. In the control situation no BHI was added. All measurements were performed in triplicate.
Comparison of protein sequences
Protein sequences of EFA0010 and homologous proteins in Staphylococcus were obtained from the NCBI database and compared using NCBI BLASTP.
Screening of qacZ in enterococcal isolates
Seventy-three enterococcal isolates were randomly selected from the laboratory collection. All these isolates were already identified to the species level and typed by PFGE. None of the selected 73 isolates is a clone. Our selection focused on three different environmental sources, namely Portuguese milk and cheese, nosocomial infections (urinary, vagina, blood culture, pus, catheter and sputum) and animal infections (cats and dogs). The dissemination of qacZ in the 73 enterococcal isolates was addressed using PCR [primers qac-IF (ATATTGCTTACG-CAAGTTGG) and qac-IR (AGTGTGATGATCCGAATGTG)]. MICs of benzalkonium chloride and chlorhexidine were also determined.
Statistical analysis
Microsoft Office Excel 2007 was used to process the data on the prevalence of qacZ and MICs obtained. The prevalence of the gene was compared using the x 2 test to determine statistically significant differences. All tests were two-tailed and tested at a level of 0.05 for significance.
Results and discussion
MIC determinations for V583ErmS and EF-SAVE1 were repeated five times and gave consistent and reproducible values: 4 mg/L of chlorhexidine for both strains; 16 mg/L of ethidium bromide for both strains; 4 mg/L of benzalkonium chloride for V583ErmS; and 8 mg/L of benzalkonium chloride for EF-SAVE1. Although the increase in MIC of benzalkonium chloride was small (from 4 to 8 mg/L), it was consistent and reproducible. This result demonstrates the involvement of qacZ in decreased susceptibility to the QAC, and not to chlorhexidine or ethidium bromide. We confirmed, by RT-PCR (data not shown), higher expression of qacZ in strain EF-SAVE1. We also observed that qacZ expression is not induced by the presence of benzalkonium chloride or ethidium bromide.
The protein encoded by EFA0010 has high similarity to several staphylococcal qac genes (Figure 1) , suggesting a role in tolerance to biocides. qac determinants are known to confer tolerance to structurally diverse compounds, including QACs, dyes and divalent cations. However, qac determinants coding for SMR transporters confer tolerance typically only to dyes and QACs, which seems not to be the case for the qacZ gene from E. faecalis. Analysis of Figure 2 clearly shows that EF-SAVE1 and V583ErmS have the same ethidium bromide efflux ability, consistent with QacZ being unable to provide resistance to ethidium bromide. Figure 1 shows that cysteine 42, which is common to all Qac proteins, is substituted by a serine in QacZ. Paulsen et al. 8 demonstrated that the substitution C42S leads to a huge decrease in the ability of QacC to provide resistance to ethidium bromide. S42 in QacZ can thus provide us with a reason for its specificity for QACs.
qacZ was detected in 63% and 70% of the strains isolated from clinical settings and dairy products, respectively, and was absent from veterinary isolates. It was detected in five different enterococcal species, and E. faecalis and Enterococcus faecium presented very similar percentages of qacZ carriage, 52% and 47%, respectively. These values are quite high, and worthy of some concern, considering that these species are simultaneously the most relevant in clinical settings and abundant in food products. MICs of benzalkonium chloride and chlorhexidine were between 2 and 8 mg/L (see Table S1 , available as Supplementary data at JAC Online), similar to other reports. 9 There was no difference in the prevalence of qacZ (P .0.05; x 2 ) between different MICs, suggesting that there are other mechanisms, probably other multidrug efflux pumps, involved in tolerance to benzalkonium chloride and chlorhexidine, as already demonstrated for staphylococcal isolates. 10 However, when comparing the frequency of the qacZ gene in isolates from different sources, a statistical difference was found (P,0.05; x 2 ), as no veterinary isolate presented this gene. We cannot rule out the hypothesis that qacZ is less disseminated in the veterinary clinical environment. A search with more strains is advisable to confirm this finding.
In summary, we provide evidence for the role of QacZ in tolerance to QACs in enterococci. The widespread and high prevalence of qacZ among the Enterococcus genus, bacteria presenting a dual role and a transversal environmental dissemination, is a cause for concern and urges future studies. 
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